secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0000950170-24-079602
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences stockholders approve all four proposals at 2024 annual meeting
--------------------------------------------------------------------------------

- Amy Yoder elected with 160,017 votes for; Lilian Shackelford Murray with 149,613 for; 501,220 broker non-votes.
- Ratification of Deloitte & Touche as auditors for FY 2024: 666,133 for, 13,547 against, 2,913 abstain.
- Amendment to 2015 Omnibus Equity Incentive Plan approved: 120,214 for, 60,507 against, 652 abstain, 501,220 broker non-votes.
- Advisory vote on executive compensation approved: 153,487 for, 27,183 against, 703 abstain, 501,220 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024079602/0000950170-24-079602-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024079602/rkda-20240625.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-079602

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer